Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science
- PMID: 30214916
- PMCID: PMC6130840
- DOI: 10.1037/bar0000113
Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science
Abstract
Behavioral pharmacology is a branch of the experimental analysis of behavior that has had great influence in drug addiction research and policy. This paper provides an overview of recent behavioral pharmacology research in the field of tobacco regulatory science, which provides the scientific foundation for the Food and Drug Administration Center for Tobacco Products (FDA CTP) to set tobacco control policies. The rationale and aims of tobacco regulatory science are provided, including the types of preclinical operant behavioral models it deems important for assessing the abuse liability of tobacco products and their constituents. We then review literature relevant to key regulatory actions being considered by the FDA CTP, including regulations over nicotine and menthol content of cigarettes, and conclude with suggesting some directions for future research. The current era of tobacco regulatory science provides great opportunities for behavioral pharmacologists to address the leading cause of preventable death and disease worldwide.
Keywords: Behavioral Pharmacology; Nicotine; Policy; Regulatory Science; Tobacco.
References
-
- Abrams DB, Herzog TA, Emmons KM, Linnan L. Stages of change versus addiction: a replication and extension. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco. 2000;2(3):223–229. - PubMed
-
- Adriani W, Laviola G. Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behavioural Pharmacology. 2004;15(5–6):341–352. - PubMed
-
- Adriani W, Macrì S, Pacifici R, Laviola G. Peculiar vulnerability to nicotine oral self-administration in mice during early adolescence. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2002;27(2):212–224. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources